Excited to share #proteomics efforts to enhance triple-negative breast cancer therapy! Thanks to @JesperOlsenLab and #HUPO2023 for making this experience unforgettable! Greetings from Busan, South Korea🌟🇰🇷
Our manuscript on Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance is out in Cell Reports https://t.co/gamsPw60YO